{"id":"W2971188595","doi":"10.1111/tbj.13516","title":"Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"The Breast Journal","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Palbociclib; Medicine; Letrozole; Fulvestrant; Internal medicine; Oncology; Hazard ratio; Metastatic breast cancer; Breast cancer; Placebo; Anastrozole; Gynecology; Cancer; Estrogen receptor; Tamoxifen; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009706167,0.000406539,0.0009740531,0.0003046505,0.0004115914,0.0004211862,0.0003656569,0.0005830981,0.002052261],"category_scores_gemma":[0.001037717,0.000360812,0.0006968181,0.0003812085,0.000557925,0.0004506398,0.0002176475,0.001243771,0.000333714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009869575,"about_ca_system_score_gemma":0.001480862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002672199,"about_ca_topic_score_gemma":0.00967795,"domain_scores_codex":[0.9996213,0.0002197834,0.0000163802,0.00005087212,0.00004272145,0.00004899585],"domain_scores_gemma":[0.9994696,0.0001195207,0.0001325047,0.00003473179,0.00004196423,0.0002017713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7585155,0.0303363,0.02025817,0.0005352493,0.00147094,0.0003003262,0.0003235056,0.001330595,0.02012876,0.0002718768,0.004783531,0.1617453],"study_design_scores_gemma":[0.3964963,0.4510761,0.135559,0.0001184153,0.001793475,0.0005472619,0.0003003655,0.001807384,0.003056563,0.0004600883,0.008718761,0.0000664221],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941987,0.0027333,0.00008769186,0.0005273591,0.0000564385,0.0002974033,0.0003465979,0.00002397147,0.001728537],"genre_scores_gemma":[0.9952319,0.001862194,0.0002280077,0.0007324109,0.00009246179,0.0004268975,0.0004591007,0.000005190038,0.0009619586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002672199,"threshold_uncertainty_score":0.007160962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01180521503603955,"score_gpt":0.2749859166840022,"score_spread":0.2631807016479627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}